Onconova Therapeutics, Inc.·4

Sep 29, 8:25 AM ET

Gelder Mark S. MD 4

4 · Onconova Therapeutics, Inc. · Filed Sep 29, 2021

Insider Transaction Report

Form 4
Period: 2021-09-28
Gelder Mark S. MD
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2021-09-28$4.20/sh+2,381$10,0002,381 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -